ARTMS Products Inc. (ARTMS), a global leader in the development of novel technologies enabling the production of the world’s highest demand diagnostic imaging isotopes, and Telix Pharmaceuticals Limited (Telix), a clinical-stage biopharmaceutical company developing diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) announced today they have entered into a development collaboration agreement to employ ARTMS’ high activity production of Gallium-68 (68Ga) for the…
Read More
The Bioinformatics Technology Lab at Canada’s Michael Smith Genome Sciences Centre (GSC) at BC Cancer has developed a new bioinformatics tool, ntJoin, which is now available for researchers to freely download and use. ntJoin is a rapid and lightweight tool for genome assembly scaffolding that leverages minimizer sketches, simultaneously making it faster while reducing the amount of memory needed in comparison to existing state-of-the-art tools.
Read More
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced it has received regulatory and ethics board approval of its Clinical Trial Application (“CTA”) to conduct its second Phase 1 trial with INM-755. The 755-102-HV clinical…
Read More
The four-year, $175,000/year chair was one of 17 awarded in early April to support in-depth investigations in specific health and social science disciplines, including aging, cancer, immunity, mental health and addictions, where the chairs are expected to drive visibility and innovation. “My research program focuses on understanding how biological sex affects metabolism,” said Dr. Rideout, an assistant professor in the…
Read More
AbCellera announced today it has received a commitment of up to $175.6 million in support from the Government of Canada under Innovation, Science and Economic Development’s (ISED) Strategic Innovation Fund (SIF) to expand efforts related to the discovery of antibodies for use in drugs to treat COVID-19, and to build technology and manufacturing infrastructure for antibody therapies against future pandemic…
Read More
This in-depth analysis of the first cohort from BC Cancer’s Personalized OncoGenomics Program provides a unique, comprehensive characterization of whole genomes and transcriptomes from pre-treated, advanced cancer patients. In addition to known resistance mechanisms, the authors identified novel genomic and transcriptomic alterations associated with prior therapy and resistance. They also analyzed the immune microenvironment across the diverse cohort of mostly metastatic tumours.
Read More
Does continuing research after the (academic) lab sound like the right career move? Industry labs work towards a specific goal or application that may seem to have a more immediate effect on society than basic research labs. If working in a fast-paced lab environment sounds interesting, then perhaps applied research at a biotech company may be the answer. Dr. Stefanie…
Read More

Dr. Stan Floresco Receives UBC Killam Teaching Prize

Dr. Stan Floresco has been awarded the UBC Killam Teaching Prize for his excellence in teaching. Dr. Floresco is a Professor in the Department of Psychology and his research program is based at the Djavad Mowafaghian Centre for Brain Health. Dr. Floresco has always been passionate about teaching and instructs a 3rd year broad-based course on brain and behaviour, and an advanced 4th…
Read More
For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart. The finding, recently published in the International Union of Crystallography Journal, brings researchers one step closer to developing new therapies to combat drug-resistant malaria. The structural differences of the metabolic…
Read More
Dr. Zabrina Brumme from SFU and the B.C. Centre for Excellence in HIV/AIDS is leading one of the dozen "rapid response" research projects funded by Genome BC based on their ability to address the most pressing questions in the fight against COVID-19. Find out which other Vancouver researchers won grants, awards, fellowships and scholarships in our April 2020 award summary!
Read More